跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/DRKS00005352
DRKS00005352已完成不适用

on interventional study with VISIPAQUE™ 270/320.

GE Healthcare Buchler GmbH & Co. KG0 个研究点目标入组 13,593 人开始时间: 2014年4月29日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
13,593
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one（—）
性别
All

入选标准

  • •non-interventional study, no influence of physicians patient selection by inclusion or exclusion criteria; Treatment according to the current SmPc

排除标准

  • •non-interventional study, no influence of physicians patient selection by inclusion or exclusion criteria; Treatment according to the current SmPc

研究者

相似试验

进行中（未招募）
1 期
A Phase 2, Interventional, Single Arm Study Describing Platelet Responses and ITPRemission Rates in Adult Subjects with Immune Thrombocytopenia Purpura ReceivingRomiplostimAdult immune thrombocytopenic purpura (ITP)MedDRA version: 12.1Level: LLTClassification code 10021245Term: Idiopathic thrombocytopenic purpura
EUCTR2010-019987-35-FRAmgen Inc75
进行中（未招募）
1 期
Interventional Study in Adult Subjects With Immune Thrombocytopenia Purpura Receiving Romiplostim
EUCTR2010-019987-35-GBAmgen Inc75
进行中（未招募）
不适用
Interventional Study in Adult Subjects With Immune Thrombocytopenia Purpura Receiving RomiplostimAdult immune thrombocytopenic purpura (ITP)MedDRA version: 16.0Level: PTClassification code 10021245Term: Idiopathic thrombocytopenic purpuraSystem Organ Class: 10005329 - Blood and lymphatic system disorders
EUCTR2010-019987-35-CZAmgen Inc75
进行中（未招募）
不适用
Interventional Study in Adult Subjects With Immune Thrombocytopenia Purpura Receiving RomiplostimAdult immune thrombocytopenic purpura (ITP)MedDRA version: 14.1Level: PTClassification code 10021245Term: Idiopathic thrombocytopenic purpuraSystem Organ Class: 10005329 - Blood and lymphatic system disorders
EUCTR2010-019987-35-DEAmgen Inc75
进行中（未招募）
不适用
A Phase 2, Interventional, Single Arm Study Describing Platelet Responses and ITP Remission Rates in Adult Subjects with Immune Thrombocytopenia Purpura Receiving Romiplostim. - Romiplostim 20080435Adult immune thrombocytopenic purpura (ITP)MedDRA version: 9.1Level: LLTClassification code 10021245
EUCTR2010-019987-35-ITAmgen Inc75
on interventional study with VISIPAQUE™ 270/320. | 临床试验